The biphasic profile often is observed in many growth factor release systems in which simple diffusion governs the growth factor release (Jha et al. 2009).
Heparin is being widely used in controlled release systems due to its strong binding ability and protective effect for many growth factor proteins.
Similarly, many growth factor receptors, for example EGF receptor, insulin receptor and c-Met, signal via huge protein complexes built on large platform proteins (Gab, Irs/Dok, p130Cas[BCAR1], Frs families etc)., which are structurally not well understood.
Indeed, many growth factor receptors mediate their cellular effects by intrinsic tyrosine kinase activity, which in turn, may phosphorylate other effector molecules involved in mitogenesis.
Traditionally, CK2 is regarded as a constitutively active protein kinase, but several studies have shown that CK2 can respond to many growth factor stimuli, including IL-6 [33], [33], although the mechanisms of its activation remain largely unclear [34].
Our finding may help improve understanding of this domain, since CK2 is connected to many growth factor or cytokine pathways, such as IL-6 and epidermal growth factor (EGF), in which Twist is also involved [20], [22], [33], [36].
Many growth factors are known to act on the external membrane of the cell, by interacting with specialized protein receptor molecules.
Many growth factors are considered to be involved in regulatory functions in the ovary.
Human platelets are a rich source of many growth factors including transforming growth factor-β and platelet-derived growth factor.
Therefore, it is plausible that many growth factors can be trapped by the newly formed fibrin fibers.
Many growth factors are involved in the development of fibrosis, such as Connective Tissue Growth Factor (CTGF), Platelet-Derived Growth Factor (PDGF) or myostatin.
